Sterling Investment Advisors (Pennsylvania)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,412
Closed -$105K 229
2022
Q2
$105K Hold
1,412
0.04% 175
2022
Q1
$181K Buy
1,412
+1,200
+566% +$131K 0.05% 147
2021
Q4
$28K Hold
212
0.01% 329
2021
Q3
$29K Hold
212
0.01% 315
2021
Q2
$23K Buy
212
+12
+6% +$1.15K 0.01% 339
2021
Q1
$18K Hold
200
0.01% 350
2020
Q4
$18K Hold
200
0.01% 313
2020
Q3
$21K Buy
200
+52
+35% +$5.43K 0.01% 289
2020
Q2
$14K Hold
148
0.01% 321
2020
Q1
$9K Buy
148
+48
+48% +$2.99K ﹤0.01% 321
2019
Q4
$5K Hold
100
﹤0.01% 366
2019
Q3
$4K Hold
100
﹤0.01% 376
2019
Q2
$4K Buy
100
+20
+25% +$629 ﹤0.01% 379
2019
Q1
$2K Hold
80
﹤0.01% 388
2018
Q4
$2K Hold
80
﹤0.01% 378
2018
Q3
$3K Buy
80
+52
+186% +$1.61K ﹤0.01% 391
2018
Q2
$0 Hold
28
﹤0.01% 389
2018
Q1
$1K Hold
28
﹤0.01% 362
2017
Q4
$0 Buy
+28
New +$364 ﹤0.01% 348

Other funds holding DXCM

Sterling Investment Advisors (Pennsylvania)'s DXCM Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of DexCom (DXCM) in Q3 2022, closing a stake of 1,412 shares — an estimated $105K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in DXCM in Q4 2017 and held it in 19 quarters. The position peaked at $181K in Q1 2022. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 1,412 DexCom shares in Q3 2022, an estimated $105K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in DexCom in Q4 2017 and held it in 19 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s DexCom position peaked at $181K in Q1 2022.
  • 795 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.